| Photodynamic therapy of cancer: an update P Agostinis, K Berg, KA Cengel, TH Foster, AW Girotti, SO Gollnick, ... CA: a cancer journal for clinicians 61 (4), 250-281, 2011 | 5897 | 2011 |
| Role of cytokines in photodynamic therapy-induced local and systemic inflammation SO Gollnick, SS Evans, H Baumann, B Owczarczak, P Maier, L Vaughan, ... British journal of cancer 88 (11), 1772-1779, 2003 | 459 | 2003 |
| Generation of effective antitumor vaccines using photodynamic therapy SO Gollnick, L Vaughan, BW Henderson Cancer research 62 (6), 1604-1608, 2002 | 383 | 2002 |
| p16 (Ink4a) and senescence-associated β-galactosidase can be induced in macrophages as part of a reversible response to physiological stimuli BM Hall, V Balan, AS Gleiberman, E Strom, P Krasnov, LP Virtuoso, ... Aging (Albany NY) 9 (8), 1867, 2017 | 354 | 2017 |
| Altered Expression of Interleukin 6 and Interleukin 10 As a Result of Photodynamic Therapy in Vivo SO Gollnick, X Liu, B Owczarczak, DA Musser, BW Henderson Cancer research 57 (18), 3904-3909, 1997 | 338 | 1997 |
| Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors BW Henderson, SO Gollnick, JW Snyder, TM Busch, PC Kousis, ... Cancer research 64 (6), 2120-2126, 2004 | 331 | 2004 |
| Photodynamic therapy enhancement of antitumor immunity is regulated by neutrophils PC Kousis, BW Henderson, PG Maier, SO Gollnick Cancer research 67 (21), 10501-10510, 2007 | 288 | 2007 |
| IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells DT Fisher, Q Chen, JJ Skitzki, JB Muhitch, L Zhou, MM Appenheimer, ... The Journal of clinical investigation 121 (10), 3846-3859, 2011 | 275 | 2011 |
| Peroxiredoxin 1 stimulates secretion of proinflammatory cytokines by binding to TLR4 JR Riddell, XY Wang, H Minderman, SO Gollnick The journal of immunology 184 (2), 1022-1030, 2010 | 244 | 2010 |
| Enhancement of anti-tumor immunity by photodynamic therapy SO Gollnick, CM Brackett Immunologic research 46, 216-226, 2010 | 209 | 2010 |
| CD8+ T cell-mediated control of distant tumours following local photodynamic therapy is independent of CD4+ T cells and dependent on natural killer cells E Kabingu, L Vaughan, B Owczarczak, KD Ramsey, SO Gollnick British journal of cancer 96 (12), 1839-1848, 2007 | 192 | 2007 |
| Murine B-cell stimulatory factor 1 (interleukin 4) increases expression of the Fc receptor for IgE on mouse B cells. SA Hudak, SO Gollnick, DH Conrad, MR Kehry Proceedings of the National Academy of Sciences 84 (13), 4606-4610, 1987 | 192 | 1987 |
| Photodynamic therapy and immunity: an update R Falk‐Mahapatra, SO Gollnick Photochemistry and photobiology 96 (3), 550-559, 2020 | 161 | 2020 |
| Photodynamic therapy and anti‐tumor immunity SO Gollnick, B Owczarczak, P Maier Lasers in Surgery and Medicine: The Official Journal of the American Society …, 2006 | 161 | 2006 |
| Enhanced systemic immune reactivity to a Basal cell carcinoma associated antigen following photodynamic therapy E Kabingu, AR Oseroff, GE Wilding, SO Gollnick Clinical Cancer Research 15 (13), 4460-4466, 2009 | 158 | 2009 |
| Peroxiredoxin 1 controls prostate cancer growth through Toll-like receptor 4–dependent regulation of tumor vasculature JR Riddell, W Bshara, MT Moser, JA Spernyak, BA Foster, SO Gollnick Cancer research 71 (5), 1637-1646, 2011 | 154 | 2011 |
| Photodynamic therapy of non–small cell lung cancer. Narrative review and future directions G Shafirstein, A Battoo, K Harris, H Baumann, SO Gollnick, J Lindenmann, ... Annals of the American Thoracic Society 13 (2), 265-275, 2016 | 145 | 2016 |
| Photodynamic therapy enhancement of anti-tumor immunity CM Brackett, SO Gollnick Photochemical & photobiological sciences 10 (5), 649-652, 2011 | 141 | 2011 |
| Water-soluble, core-modified porphyrins as novel, longer-wavelength-absorbing sensitizers for photodynamic therapy. II. Effects of core heteroatoms and meso-substituents on … DG Hilmey, M Abe, MI Nelen, CE Stilts, GA Baker, SN Baker, FV Bright, ... Journal of medicinal chemistry 45 (2), 449-461, 2002 | 132 | 2002 |
| Development of photodynamic therapy regimens that control primary tumor growth and inhibit secondary disease M Shams, B Owczarczak, P Manderscheid-Kern, DA Bellnier, SO Gollnick Cancer Immunology, Immunotherapy 64, 287-297, 2015 | 124 | 2015 |